ACCEL
Live / Applied — Second extension granted (statement of use) (as of 18 Feb 2026)
What this means for you
Not registered yet, but its 21 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98280621
- Mark type
- Stylized text
- Filed
- 21 Nov 2023
- Published for opposition
- 07 Jan 2025
- Attorney of record
- Christopher Bolinger
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for treatment of cancer and viral-infected cells; pharmaceuticals in the nature of biologic agents for adoptive cellular therapy
Owner
- Xyphos Biosciences, Inc., South San Francisco, CA, US
- Xyphos Biosciences, Inc., South San Francisco, CA, US
Prosecution history
- 19 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Feb 2026 — SOU EXTENSION 2 GRANTED
- 18 Feb 2026 — SOU EXTENSION 2 FILED
- 18 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Sept 2025 — SOU EXTENSION 1 GRANTED
- 02 Sept 2025 — SOU EXTENSION 1 FILED
- 02 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 20 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED